ReviewDiabetes/metabolism research and reviews2021

Changing the approach to type 2 diabetes treatment: A comparison of glucagon-like peptide-1 receptor agonists and sulphonylureas across the continuum of care.

Marco Orsini Federici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.